Serina Therapeutics, Inc.SERNYSE
Loading
Operating cash flow minus capital expenditures
Latest
$-16.53M
↓ 96% vs avg
Percentile
P11
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-8.44M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-16.53M | +3.7% |
| 2024 | $-17.16M | -475.8% |
| 2023 | $-2.98M | -42.9% |
| 2022 | $-2.09M | +11.6% |
| 2021 | $-2.36M | +69.9% |
| 2020 | $-7.84M | +27.4% |
| 2019 | $-10.80M | -9.2% |
| 2018 | $-9.89M | -57.3% |
| 2017 | $-6.29M | +25.6% |
| 2016 | $-8.45M | - |